Table 2.
All (n = 465) | Non-purulent group (n = 369) | Purulent group (n = 96) | P-value | |
---|---|---|---|---|
Lower extremities involved (%) | 364 (78.3) | 304 (82.4) | 60 (62.5) | <0.001 |
Sepsis at admission (%) | 127 (27.3) | 103 (27.9) | 24 (25.0) | 0.568 |
WBC, mean 109/L (SD) | 10.3 (4.9) | 10.2 (5.0) | 10.5 (4.8) | 0.572 |
Hb (g/dL), mean (SD) | 12.9 (2.2) | 12.9 (2.2) | 13.0 (2.3) | 0.658 |
PLT/mm3 (SD) | 200.6 (78.9) | 195.0 (77.2) | 221.9 (82) | 0.003 |
Lactic acid (mmol/L), mean (SD) | 1.8 (1.2) | 1.8 (1.2) | 1.9 (1.3) | 0.917 |
Cr (mg/dL), mean (SD) | 1.3 (1.7) | 1.4 (1.9) | 1.1 (0.7) | 0.175 |
CK (U/L), mean (SD) | 142.1 (343) | 144.2 (368) | 131.8 (165.9) | 0.813 |
CRP (mg/dL), mean (SD) | 6.3 (7.6) | 6.3 (7.7) | 6.3 (7.4) | 0.993 |
GOT (IU/L), mean (range) | 31.0 (23.6) | 30.4 (19.8) | 33.2 (34.4) | 0.5 |
Albumin (g/dL), mean (SD) | 3.1 (0.7) | 3.1 (0.7) | 3.2 (0.6) | 0.71 |
Recurrence within 6 months (%) | 57 (12.3) | 54 (14.6) | 3 (3.1) | 0.001 |
Death within 30 days (%) | 3 (0.6) | 3 (0.8) | 0 (0) | 1.0 |
Length of stay, days (SD) | 9 (6.5) | 8 (5.8) | 11 (8.1) | 0.001 |
Duration of antimicrobial therapy, days (SD) | 14 (9.7) | 13 (9) | 17 (12) | 0.003 |
Data are number (%) of patients, unless otherwise indicated
CK creatine kinase, Cr creatinine, CRP C-reactive protein, GOT glutamate oxaloacetate transaminase, Hb hemoglobin, PLT platelet count, SD standard deviation